25 XP   0   0   10

Clearside Biomedical Inc
Buy, Hold or Sell?

Let's analyse Clearside Biomedical Inc together

PenkeI guess you are interested in Clearside Biomedical Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Clearside Biomedical Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Clearside Biomedical Inc

I send you an email if I find something interesting about Clearside Biomedical Inc.

Quick analysis of Clearside Biomedical Inc (30 sec.)










What can you expect buying and holding a share of Clearside Biomedical Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
2.7%

What is your share worth?

Current worth
$-0.21
Expected worth in 1 year
$-0.57
How sure are you?
27.0%

+ What do you gain per year?

Total Gains per Share
$-0.35
Return On Investment
-26.9%

For what price can you sell your share?

Current Price per Share
$1.32
Expected price per share
$0.9243 - $2.12
How sure are you?
50%

1. Valuation of Clearside Biomedical Inc (5 min.)




Live pricePrice per Share (EOD)

$1.32

Intrinsic Value Per Share

$1.55 - $1.95

Total Value Per Share

$1.33 - $1.74

2. Growth of Clearside Biomedical Inc (5 min.)




Is Clearside Biomedical Inc growing?

Current yearPrevious yearGrowGrow %
How rich?-$15.9m$21.5m-$29.2m-377.5%

How much money is Clearside Biomedical Inc making?

Current yearPrevious yearGrowGrow %
Making money-$9m-$8.2m-$844.3k-9.3%
Net Profit Margin-82,524.9%-2,547.6%--

How much money comes from the company's main activities?

3. Financial Health of Clearside Biomedical Inc (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#967 / 1016

Most Revenue
#444 / 1016

Most Profit
#536 / 1016

Most Efficient
#996 / 1016

What can you expect buying and holding a share of Clearside Biomedical Inc? (5 min.)

Welcome investor! Clearside Biomedical Inc's management wants to use your money to grow the business. In return you get a share of Clearside Biomedical Inc.

What can you expect buying and holding a share of Clearside Biomedical Inc?

First you should know what it really means to hold a share of Clearside Biomedical Inc. And how you can make/lose money.

Speculation

The Price per Share of Clearside Biomedical Inc is $1.32. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Clearside Biomedical Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Clearside Biomedical Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $-0.21. Based on the TTM, the Book Value Change Per Share is $-0.09 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.09 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Clearside Biomedical Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.06-4.9%-0.11-8.2%-0.11-8.4%-0.08-5.8%-0.13-10.1%
Usd Book Value Change Per Share-0.04-3.1%-0.09-6.7%-0.09-6.9%-0.03-2.0%-0.01-0.5%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.2%
Usd Total Gains Per Share-0.04-3.1%-0.09-6.7%-0.09-6.9%-0.03-2.0%0.00-0.3%
Usd Price Per Share1.17-1.05-1.50-2.00-3.64-
Price to Earnings Ratio-4.52--2.67--3.49--6.31--7.65-
Price-to-Total Gains Ratio-28.54--14.38--16.86-5.06--6.55-
Price to Book Ratio-5.49-0.35-5.55-9.45-7.71-
Price-to-Total Gains Ratio-28.54--14.38--16.86-5.06--6.55-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.32
Number of shares757
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.09-0.03
Usd Total Gains Per Share-0.09-0.03
Gains per Quarter (757 shares)-67.17-20.02
Gains per Year (757 shares)-268.66-80.10
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-269-2790-80-90
20-537-5480-160-170
30-806-8170-240-250
40-1075-10860-320-330
50-1343-13550-400-410
60-1612-16240-481-490
70-1881-18930-561-570
80-2149-21620-641-650
90-2418-24310-721-730
100-2687-27000-801-810

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%1.011.00.08.3%1.019.00.05.0%1.036.00.02.7%1.036.01.02.6%
Book Value Change Per Share0.04.00.00.0%3.09.00.025.0%6.014.00.030.0%10.025.02.027.0%11.025.02.028.9%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%1.00.036.02.7%1.00.037.02.6%
Total Gains per Share0.04.00.00.0%3.09.00.025.0%6.014.00.030.0%10.025.02.027.0%11.025.02.028.9%

Fundamentals of Clearside Biomedical Inc

About Clearside Biomedical Inc

Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. It offers XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of uveitis macular edema. It also develops CLS-AX, an axitinib injectable suspension for suprachoroidal injection, which is in Phase IIb clinical trial to treat wet AMD. The company has a collaboration with Bausch Health, Arctic Vision, REGENXBIO, Inc., BioCryst Pharmaceuticals, Inc., and Aura Biosciences. Clearside Biomedical, Inc. was incorporated in 2011 and is headquartered in Alpharetta, Georgia.

Fundamental data was last updated by Penke on 2024-04-11 04:25:02.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is just not able to pay all its debts by selling its assets.
The company is unable to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is cheap.

1.1. Profitability of Clearside Biomedical Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Clearside Biomedical Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Clearside Biomedical Inc to the Biotechnology industry mean.
  • A Net Profit Margin of -76.2% means that $-0.76 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Clearside Biomedical Inc:

  • The MRQ is -76.2%. The company is making a huge loss. -2
  • The TTM is -82,524.9%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-76.2%TTM-82,524.9%+82,448.7%
TTM-82,524.9%YOY-2,547.6%-79,977.3%
TTM-82,524.9%5Y-24,048.4%-58,476.5%
5Y-24,048.4%10Y-33,862.2%+9,813.8%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-76.2%-197.2%+121.0%
TTM-82,524.9%-210.4%-82,314.5%
YOY-2,547.6%-279.3%-2,268.3%
5Y-24,048.4%-436.8%-23,611.6%
10Y-33,862.2%-599.3%-33,262.9%
1.1.2. Return on Assets

Shows how efficient Clearside Biomedical Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Clearside Biomedical Inc to the Biotechnology industry mean.
  • -14.2% Return on Assets means that Clearside Biomedical Inc generated $-0.14 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Clearside Biomedical Inc:

  • The MRQ is -14.2%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -23.4%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-14.2%TTM-23.4%+9.2%
TTM-23.4%YOY-19.8%-3.6%
TTM-23.4%5Y-19.3%-4.1%
5Y-19.3%10Y-24.2%+4.8%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-14.2%-13.6%-0.6%
TTM-23.4%-12.9%-10.5%
YOY-19.8%-11.9%-7.9%
5Y-19.3%-14.2%-5.1%
10Y-24.2%-16.2%-8.0%
1.1.3. Return on Equity

Shows how efficient Clearside Biomedical Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Clearside Biomedical Inc to the Biotechnology industry mean.
  • 0.0% Return on Equity means Clearside Biomedical Inc generated $0.00 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Clearside Biomedical Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-121.5%+121.5%
TTM-121.5%YOY-46.0%-75.5%
TTM-121.5%5Y-58.8%-62.7%
5Y-58.8%10Y-66.4%+7.6%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--17.0%+17.0%
TTM-121.5%-16.1%-105.4%
YOY-46.0%-15.4%-30.6%
5Y-58.8%-20.0%-38.8%
10Y-66.4%-21.1%-45.3%

1.2. Operating Efficiency of Clearside Biomedical Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Clearside Biomedical Inc is operating .

  • Measures how much profit Clearside Biomedical Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Clearside Biomedical Inc to the Biotechnology industry mean.
  • An Operating Margin of -45.9% means the company generated $-0.46  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Clearside Biomedical Inc:

  • The MRQ is -45.9%. The company is operating very inefficient. -2
  • The TTM is -47,915.8%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-45.9%TTM-47,915.8%+47,869.8%
TTM-47,915.8%YOY-2,306.9%-45,608.9%
TTM-47,915.8%5Y-17,225.3%-30,690.5%
5Y-17,225.3%10Y-29,769.3%+12,544.1%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-45.9%-286.1%+240.2%
TTM-47,915.8%-224.4%-47,691.4%
YOY-2,306.9%-288.4%-2,018.5%
5Y-17,225.3%-475.2%-16,750.1%
10Y-29,769.3%-624.7%-29,144.6%
1.2.2. Operating Ratio

Measures how efficient Clearside Biomedical Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 1.46 means that the operating costs are $1.46 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Clearside Biomedical Inc:

  • The MRQ is 1.459. The company is inefficient in keeping operating costs low. -1
  • The TTM is 481.245. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.459TTM481.245-479.785
TTM481.245YOY24.105+457.139
TTM481.2455Y187.030+294.214
5Y187.03010Y482.666-295.636
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.4592.997-1.538
TTM481.2453.247+477.998
YOY24.1053.766+20.339
5Y187.0305.675+181.355
10Y482.6667.857+474.809

1.3. Liquidity of Clearside Biomedical Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Clearside Biomedical Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 4.42 means the company has $4.42 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Clearside Biomedical Inc:

  • The MRQ is 4.421. The company is very able to pay all its short-term debts. +2
  • The TTM is 6.272. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ4.421TTM6.272-1.851
TTM6.272YOY8.234-1.961
TTM6.2725Y4.702+1.571
5Y4.70210Y13.198-8.496
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ4.4213.930+0.491
TTM6.2724.251+2.021
YOY8.2345.436+2.798
5Y4.7026.045-1.343
10Y13.1986.363+6.835
1.3.2. Quick Ratio

Measures if Clearside Biomedical Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Clearside Biomedical Inc to the Biotechnology industry mean.
  • A Quick Ratio of 4.27 means the company can pay off $4.27 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Clearside Biomedical Inc:

  • The MRQ is 4.270. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 6.088. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ4.270TTM6.088-1.818
TTM6.088YOY8.076-1.987
TTM6.0885Y4.548+1.541
5Y4.54810Y17.903-13.356
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ4.2703.629+0.641
TTM6.0884.065+2.023
YOY8.0765.397+2.679
5Y4.5485.993-1.445
10Y17.9036.277+11.626

1.4. Solvency of Clearside Biomedical Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Clearside Biomedical Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Clearside Biomedical Inc to Biotechnology industry mean.
  • A Debt to Asset Ratio of 1.47 means that Clearside Biomedical Inc assets are financed with 146.8% credit (debt) and the remaining percentage (100% - 146.8%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Clearside Biomedical Inc:

  • The MRQ is 1.468. The company is unable to pay all its debts by selling its assets. -2
  • The TTM is 1.227. The company is just not able to pay all its debts by selling its assets. -1
Trends
Current periodCompared to+/- 
MRQ1.468TTM1.227+0.241
TTM1.227YOY0.440+0.787
TTM1.2275Y0.622+0.605
5Y0.62210Y1.005-0.383
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.4680.332+1.136
TTM1.2270.334+0.893
YOY0.4400.268+0.172
5Y0.6220.366+0.256
10Y1.0050.390+0.615
1.4.2. Debt to Equity Ratio

Measures if Clearside Biomedical Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Clearside Biomedical Inc to the Biotechnology industry mean.
  • A Debt to Equity ratio of 0.0% means that company has $0.00 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Clearside Biomedical Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM3.888-3.888
TTM3.888YOY1.549+2.340
TTM3.8885Y1.720+2.168
5Y1.72010Y2.509-0.789
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.381-0.381
TTM3.8880.390+3.498
YOY1.5490.334+1.215
5Y1.7200.434+1.286
10Y2.5090.466+2.043

2. Market Valuation of Clearside Biomedical Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Clearside Biomedical Inc generates.

  • Above 15 is considered overpriced but always compare Clearside Biomedical Inc to the Biotechnology industry mean.
  • A PE ratio of -4.52 means the investor is paying $-4.52 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Clearside Biomedical Inc:

  • The EOD is -5.103. Based on the earnings, the company is expensive. -2
  • The MRQ is -4.523. Based on the earnings, the company is expensive. -2
  • The TTM is -2.667. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-5.103MRQ-4.523-0.580
MRQ-4.523TTM-2.667-1.856
TTM-2.667YOY-3.493+0.826
TTM-2.6675Y-6.310+3.643
5Y-6.31010Y-7.652+1.342
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-5.103-2.315-2.788
MRQ-4.523-2.560-1.963
TTM-2.667-2.664-0.003
YOY-3.493-4.122+0.629
5Y-6.310-6.258-0.052
10Y-7.652-6.108-1.544
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Clearside Biomedical Inc:

  • The EOD is 65.755. Based on how much money comes from the company's main activities, the company is overpriced. -1
  • The MRQ is 58.282. Based on how much money comes from the company's main activities, the company is overpriced. -1
  • The TTM is 12.472. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD65.755MRQ58.282+7.472
MRQ58.282TTM12.472+45.810
TTM12.472YOY-0.249+12.721
TTM12.4725Y-0.735+13.208
5Y-0.73510Y-5.237+4.502
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD65.755-3.067+68.822
MRQ58.282-3.251+61.533
TTM12.472-3.545+16.017
YOY-0.249-5.595+5.346
5Y-0.735-8.315+7.580
10Y-5.237-8.708+3.471
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Clearside Biomedical Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of -5.49 means the investor is paying $-5.49 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Clearside Biomedical Inc:

  • The EOD is -6.199. Based on the equity, the company is expensive. -2
  • The MRQ is -5.494. Based on the equity, the company is expensive. -2
  • The TTM is 0.350. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD-6.199MRQ-5.494-0.704
MRQ-5.494TTM0.350-5.844
TTM0.350YOY5.548-5.198
TTM0.3505Y9.453-9.103
5Y9.45310Y7.705+1.748
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-6.1991.905-8.104
MRQ-5.4942.111-7.605
TTM0.3502.095-1.745
YOY5.5482.836+2.712
5Y9.4533.443+6.010
10Y7.7053.794+3.911
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Clearside Biomedical Inc.

3.1. Institutions holding Clearside Biomedical Inc

Institutions are holding 21.234% of the shares of Clearside Biomedical Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31Vanguard Group Inc2.91260.0001217631694310.4352
2023-12-31Carmignac Gestion2.85430.0419213274400
2023-12-31BlackRock Inc1.01680759743-3489-0.4571
2023-12-31Geode Capital Management, LLC0.65670.000149069000
2023-12-31Renaissance Technologies Corp0.51480.000738468911140040.7627
2023-12-31State Street Corporation0.2588019336300
2023-12-31Bridgeway Capital Management, LLC0.2350.004417560000
2023-12-31First Manhattan Co. LLC0.23420.000717500000
2023-12-31Johnson & Johnson0.2270.004516962900
2023-12-31Morgan Stanley - Brokerage Accounts0.19330144434-23338-13.9105
2023-12-31Brown Wealth Management, LLC0.14720.05711000000
2023-12-31Northeast Financial Consultants, Inc0.12450.006930001000012.0482
2023-12-31Northern Trust Corp0.1228091777-3006-3.1715
2023-12-31Susquehanna International Group, LLP0.12060900933109152.6948
2023-12-31Synovus Financial Corp0.0710.000953071-5000-8.6101
2023-12-31CapTrust Financial Advisors0.06690.00025000000
2023-12-31Natixis SA0.06360.000447500475000
2023-12-31Banque Cantonale Vaudoise0.05350.0024000000
2023-12-31Stifel Financial Corp0.04560.000134044-19500-36.4186
2023-12-31Millennium Management LLC0.045033638336380
Total 9.96420.1197445331+188727+2.5%

3.2. Funds holding Clearside Biomedical Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-02-29Vanguard Total Stock Mkt Idx Inv2.18840.0002163520100
2024-01-31Carmignac Pf L-S Eurp Eqs F EUR Acc2.01860.3138150834200
2024-02-29Vanguard Institutional Extnd Mkt Idx Tr0.94690.0017075343140.0444
2024-01-31Carmignac Absolute Ret Eur A EUR Acc0.83560.35262440200
2024-02-29Fidelity Extended Market Index0.38350.0011286574-1389-0.4824
2023-12-31Bridgeway Ultra-Small Company Market0.2350.110617560000
2023-09-30BlackRock Extended Mkt Composite0.19440.000914527900
2024-03-31BlackRock Extended Equity Market K0.16970.0013126789460.0363
2024-03-28iShares Micro-Cap ETF0.16290.020312174200
2024-02-29Fidelity Total Market Index0.10150.00017581200
2024-02-29Fidelity Series Total Market Index0.09160.00016845500
2023-12-31NT Ext Equity Mkt Idx Fd - NL0.05880.00084395300
2023-12-31Northern Trust Extended Eq Market Idx0.05810.00094341100
2023-12-31NT Ext Equity Mkt Idx Fd - L0.05810.00094341100
2024-02-29Fidelity Nasdaq Composite Index0.0510.00033807900
2023-12-31NT Ext Equity Mkt Idx Fd - DC - NL - T20.04720.000835300660.1873
2024-02-29Vanguard Balanced Index Inv0.04480.00013350000
2023-10-31Vanguard Instl Ttl Stck Mkt Idx Tr0.04470.000133371-1350283-97.5882
2024-02-29Vanguard Instl Ttl Stk Mkt Idx InstlPls0.04470.00013337100
2024-03-31BlackRock U.S. Equity Market F0.03220.0002240242320.9751
Total 7.76770.80565804150-1351014-23.3%

3.3. Insider Transactions

Insiders are holding 7.165% of the shares of Clearside Biomedical Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2024-03-20Ngai Hang Victor ChongBUY300001.6
2024-02-07Bradford T WhitmoreBUY4444441.35
2024-01-19Charles A DeignanSELL129001.28
2024-01-19George M LasezkaySELL180001.27
2023-11-01Bradford T WhitmoreBUY643660.74
2023-10-30Bradford T WhitmoreBUY6000.69
2023-10-03Nancy J HutsonBUY100000.86
2023-09-25Clay ThorpBUY100000.86

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Clearside Biomedical Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.041-0.089+116%-0.092+123%-0.026-35%-0.006-85%
Book Value Per Share---0.213-0.104-51%0.288-174%0.155-237%0.207-203%
Current Ratio--4.4216.272-30%8.234-46%4.702-6%13.198-66%
Debt To Asset Ratio--1.4681.227+20%0.440+234%0.622+136%1.005+46%
Debt To Equity Ratio---3.888-100%1.549-100%1.720-100%2.509-100%
Dividend Per Share----0%-0%-0%0.002-100%
Eps---0.065-0.109+68%-0.110+70%-0.076+18%-0.133+105%
Free Cash Flow Per Share--0.005-0.067+1427%-0.046+1007%-0.057+1228%-0.092+1933%
Free Cash Flow To Equity Per Share--0.002-0.065+4231%0.059-97%-0.008+630%0.006-75%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--1.951--------
Intrinsic Value_10Y_min--1.547--------
Intrinsic Value_1Y_max---0.141--------
Intrinsic Value_1Y_min---0.138--------
Intrinsic Value_3Y_max---0.167--------
Intrinsic Value_3Y_min---0.164--------
Intrinsic Value_5Y_max--0.117--------
Intrinsic Value_5Y_min--0.086--------
Market Cap98631857.280+11%87423691.68078455291.172+11%112268458.760-22%149598001.502-42%272170005.729-68%
Net Profit Margin---0.762-825.249+108265%-25.476+3245%-240.484+31478%-338.622+44365%
Operating Margin---0.459-479.158+104197%-23.069+4921%-172.253+37394%-297.693+64698%
Operating Ratio--1.459481.245-100%24.105-94%187.030-99%482.666-100%
Pb Ratio-6.199-13%-5.4940.350-1670%5.548-199%9.453-158%7.705-171%
Pe Ratio-5.103-13%-4.523-2.667-41%-3.493-23%-6.310+40%-7.652+69%
Price Per Share1.320+11%1.1701.050+11%1.503-22%2.002-42%3.642-68%
Price To Free Cash Flow Ratio65.755+11%58.28212.472+367%-0.249+100%-0.735+101%-5.237+109%
Price To Total Gains Ratio-32.201-13%-28.542-14.382-50%-16.859-41%5.059-664%-6.554-77%
Quick Ratio--4.2706.088-30%8.076-47%4.548-6%17.903-76%
Return On Assets---0.142-0.234+65%-0.198+40%-0.193+36%-0.242+70%
Return On Equity----1.2150%-0.4600%-0.5880%-0.6640%
Total Gains Per Share---0.041-0.089+116%-0.092+123%-0.026-35%-0.004-90%
Usd Book Value---15912000.000-7758500.000-51%21526000.000-174%11586900.000-237%15497432.432-203%
Usd Book Value Change Per Share---0.041-0.089+116%-0.092+123%-0.026-35%-0.006-85%
Usd Book Value Per Share---0.213-0.104-51%0.288-174%0.155-237%0.207-203%
Usd Dividend Per Share----0%-0%-0%0.002-100%
Usd Eps---0.065-0.109+68%-0.110+70%-0.076+18%-0.133+105%
Usd Free Cash Flow--375000.000-4978000.000+1427%-3402750.000+1007%-4230450.000+1228%-6875378.378+1933%
Usd Free Cash Flow Per Share--0.005-0.067+1427%-0.046+1007%-0.057+1228%-0.092+1933%
Usd Free Cash Flow To Equity Per Share--0.002-0.065+4231%0.059-97%-0.008+630%0.006-75%
Usd Market Cap98631857.280+11%87423691.68078455291.172+11%112268458.760-22%149598001.502-42%272170005.729-68%
Usd Price Per Share1.320+11%1.1701.050+11%1.503-22%2.002-42%3.642-68%
Usd Profit---4832000.000-9081750.000+88%-8237417.500+70%-5894033.500+22%-8266423.514+71%
Usd Revenue--6345000.0002056500.000+209%331750.000+1813%2459750.000+158%1355270.270+368%
Usd Total Gains Per Share---0.041-0.089+116%-0.092+123%-0.026-35%-0.004-90%
 EOD+5 -3MRQTTM+23 -9YOY+19 -135Y+16 -1610Y+14 -20

4.2. Fundamental Score

Let's check the fundamental score of Clearside Biomedical Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-5.103
Price to Book Ratio (EOD)Between0-1-6.199
Net Profit Margin (MRQ)Greater than0-0.762
Operating Margin (MRQ)Greater than0-0.459
Quick Ratio (MRQ)Greater than14.270
Current Ratio (MRQ)Greater than14.421
Debt to Asset Ratio (MRQ)Less than11.468
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-0.142
Total3/10 (30.0%)

4.3. Technical Score

Let's check the technical score of Clearside Biomedical Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5045.762
Ma 20Greater thanMa 501.428
Ma 50Greater thanMa 1001.450
Ma 100Greater thanMa 2001.327
OpenGreater thanClose1.280
Total2/5 (40.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-12-312023-03-312023-06-302023-09-302023-12-31
Net Debt  -46,9736,777-40,1966,346-33,8506,134-27,71641,79714,081



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets34,018
Total Liabilities49,930
Total Stockholder Equity-15,912
 As reported
Total Liabilities 49,930
Total Stockholder Equity+ -15,912
Total Assets = 34,018

Assets

Total Assets34,018
Total Current Assets30,123
Long-term Assets3,895
Total Current Assets
Cash And Cash Equivalents 28,920
Net Receivables 170
Other Current Assets 1,033
Total Current Assets  (as reported)30,123
Total Current Assets  (calculated)30,123
+/-0
Long-term Assets
Property Plant Equipment 3,865
Long-term Assets Other 30
Long-term Assets  (as reported)3,895
Long-term Assets  (calculated)3,895
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities6,813
Long-term Liabilities43,117
Total Stockholder Equity-15,912
Total Current Liabilities
Short-term Debt 364
Accounts payable 2,205
Other Current Liabilities 4,169
Total Current Liabilities  (as reported)6,813
Total Current Liabilities  (calculated)6,738
+/- 75
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt649
Long-term Liabilities Other 42,468
Long-term Liabilities  (as reported)43,117
Long-term Liabilities  (calculated)43,117
+/-0
Total Stockholder Equity
Common Stock63
Retained Earnings -320,923
Other Stockholders Equity 304,948
Total Stockholder Equity (as reported)-15,912
Total Stockholder Equity (calculated)-15,912
+/-0
Other
Capital Stock63
Cash and Short Term Investments 28,920
Common Stock Shares Outstanding 62,404
Current Deferred Revenue75
Liabilities and Stockholders Equity 34,018
Net Debt 14,081
Net Invested Capital -15,912
Net Working Capital 23,310
Property Plant and Equipment Gross 4,785
Short Long Term Debt Total 43,001



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312013-12-31
> Total Assets 
2,137
10,299
0
0
4,516
21,055
16,913
56,164
57,771
84,813
81,958
68,415
54,875
40,493
104,462
88,016
69,381
44,120
37,534
29,854
25,867
26,776
25,043
17,738
17,405
19,322
27,821
28,592
27,378
42,903
36,059
30,746
55,685
51,303
44,695
39,185
34,420
34,018
34,01834,42039,18544,69551,30355,68530,74636,05942,90327,37828,59227,82119,32217,40517,73825,04326,77625,86729,85437,53444,12069,38188,016104,46240,49354,87568,41581,95884,81357,77156,16416,91321,0554,5160010,2992,137
   > Total Current Assets 
0
8,323
0
0
4,362
20,482
15,967
56,033
56,919
83,631
80,484
66,035
53,480
37,640
103,229
86,821
68,189
42,944
35,468
27,893
24,046
25,219
23,505
16,277
16,022
18,118
26,699
27,653
26,523
42,136
35,274
29,989
54,862
48,258
42,567
36,107
30,815
30,123
30,12330,81536,10742,56748,25854,86229,98935,27442,13626,52327,65326,69918,11816,02216,27723,50525,21924,04627,89335,46842,94468,18986,821103,22937,64053,48066,03580,48483,63156,91956,03315,96720,4824,362008,3230
       Cash And Cash Equivalents 
1,909
8,269
0
0
4,186
20,283
15,887
55,279
56,919
34,824
22,989
16,675
16,289
9,224
84,834
35,185
15,841
8,043
32,950
26,174
22,551
22,595
20,930
15,071
14,839
17,287
26,147
26,414
25,217
30,436
34,372
29,033
53,381
48,258
41,419
35,005
28,802
28,920
28,92028,80235,00541,41948,25853,38129,03334,37230,43625,21726,41426,14717,28714,83915,07120,93022,59522,55126,17432,9508,04315,84135,18584,8349,22416,28916,67522,98934,82456,91955,27915,88720,2834,186008,2691,909
       Short-term Investments 
0
48,807
0
0
0
48,807
0
0
20,043
48,807
54,462
49,360
36,338
28,416
16,221
49,245
49,101
32,835
1,988
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000001,98832,83549,10149,24516,22128,41636,33849,36054,46248,80720,0430048,80700048,8070
       Net Receivables 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
10,000
0
123
123
0
0
255
882
170
17088225500123123010,00000000000000000000000000000000
       Inventory 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
921
0
439
1,047
0
0
542
1,117
0
01,117542001,047439092100000000000000000000000000000
   > Long-term Assets 
0
1,976
0
0
154
573
946
131
852
360
1,474
360
1,395
360
1,233
1,195
1,192
1,176
2,066
1,961
1,821
1,557
1,538
1,461
1,383
1,204
1,122
939
855
767
785
757
823
3,045
2,128
3,078
3,605
3,895
3,8953,6053,0782,1283,0458237577857678559391,1221,2041,3831,4611,5381,5571,8211,9612,0661,1761,1921,1951,2333601,3953601,474360852131946573154001,9760
       Property Plant Equipment 
98
205
0
0
147
156
139
124
110
94
1,010
963
932
885
838
791
778
790
1,680
1,575
1,461
1,197
1,178
1,101
1,023
944
862
779
695
607
625
597
663
1,872
2,098
3,048
3,575
3,865
3,8653,5753,0482,0981,8726635976256076957798629441,0231,1011,1781,1971,4611,5751,6807907787918388859329631,010941101241391561470020598
       Long-term Assets Other 
0
1,771
0
0
7
417
807
7
742
266
464
-603
463
-525
395
404
414
386
386
386
360
360
360
360
360
260
260
160
160
160
160
160
160
1,143
30
30
30
30
303030301,143160160160160160160260260360360360360360386386386414404395-525463-60346426674278074177001,7710
> Total Liabilities 
1,004
29,512
0
0
36,076
57,714
11,447
10,268
113,370
13,154
14,795
14,089
17,980
19,078
18,531
21,344
25,300
20,500
21,443
16,953
16,108
15,619
14,603
10,451
9,281
10,559
10,836
9,254
9,530
4,928
4,356
5,498
37,139
40,696
41,995
44,158
47,269
49,930
49,93047,26944,15841,99540,69637,1395,4984,3564,9289,5309,25410,83610,5599,28110,45114,60315,61916,10816,95321,44320,50025,30021,34418,53119,07817,98014,08914,79513,154113,37010,26811,44757,71436,0760029,5121,004
   > Total Current Liabilities 
683
2,424
0
0
3,156
5,196
7,314
6,733
185
5,408
7,186
7,136
11,695
13,519
13,843
10,946
14,865
10,476
11,666
8,041
10,818
10,903
13,771
9,193
8,207
9,943
10,297
8,796
9,156
4,640
4,156
5,393
5,204
5,783
4,984
5,274
5,835
6,813
6,8135,8355,2744,9845,7835,2045,3934,1564,6409,1568,79610,2979,9438,2079,19313,77110,90310,8188,04111,66610,47614,86510,94613,84313,51911,6957,1367,1865,4081856,7337,3145,1963,156002,424683
       Short-term Debt 
0
1,733
0
0
1,133
1,733
2,333
2,400
-1,372
2,631
800
1,600
2,400
3,200
3,200
49,245
49,101
556
1,888
2,726
6,316
1,693
5,546
861
976
1,364
377
380
384
387
391
395
407
349
356
359
362
364
3643623593563494073953913873843803771,3649768615,5461,6936,3162,7261,88855649,10149,2453,2003,2002,4001,6008002,631-1,3722,4002,3331,7331,133001,7330
       Short Long Term Debt 
0
1,733
0
0
0
1,733
0
2,400
800
7,586
800
7,796
2,400
3,200
3,200
9,848
0
556
1,389
2,222
5,833
1,333
5,183
495
606
991
0
0
0
0
0
0
0
0
0
0
0
0
0000000000009916064955,1831,3335,8332,2221,38955609,8483,2003,2002,4007,7968007,5868002,40001,7330001,7330
       Accounts payable 
248
1,257
0
0
750
1,469
2,492
2,366
1,347
2,594
4,716
3,732
5,075
5,384
6,744
8,372
11,910
6,869
5,258
2,227
1,429
1,280
1,633
1,698
909
1,997
2,343
1,220
776
941
1,396
2,644
1,739
1,050
1,594
1,886
1,867
2,205
2,2051,8671,8861,5941,0501,7392,6441,3969417761,2202,3431,9979091,6981,6331,2801,4292,2275,2586,86911,9108,3726,7445,3845,0753,7324,7162,5941,3472,3662,4921,469750001,257248
       Other Current Liabilities 
435
1,167
0
0
1,273
1,994
2,469
1,947
25
23
1,515
1,654
4,075
4,795
3,899
2,574
2,955
3,051
4,520
225
375
2,930
1,492
1,634
1,322
1,582
2,577
2,196
2,996
3,312
2,171
2,354
2,945
4,179
2,754
2,674
3,606
4,169
4,1693,6062,6742,7544,1792,9452,3542,1713,3122,9962,1962,5771,5821,3221,6341,4922,9303752254,5203,0512,9552,5743,8994,7954,0751,6541,51523251,9472,4691,9941,273001,167435
   > Long-term Liabilities 
0
27,088
0
0
32,920
52,518
4,133
3,535
113,185
7,586
7,609
7,796
6,285
8,009
4,688
10,398
10,435
10,024
9,777
8,912
5,290
4,716
832
1,258
1,074
616
539
458
374
288
200
105
31,935
33,977
37,011
38,884
41,434
43,117
43,11741,43438,88437,01133,97731,9351052002883744585396161,0741,2588324,7165,2908,9129,77710,02410,43510,3984,6888,0096,2857,7967,6097,586113,1853,5354,13352,51832,9200027,0880
       Long term Debt Total 
0
0
0
0
0
0
0
3,286
7,489
7,586
6,891
6,196
5,503
4,809
4,107
9,848
9,911
9,419
8,647
7,877
4,329
3,819
0
496
385
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000038549603,8194,3297,8778,6479,4199,9119,8484,1074,8095,5036,1966,8917,5867,4893,2860000000
       Capital Lease Obligations Min Short Term Debt
0
-1,733
0
0
-1,133
-1,733
-2,333
-2,400
1,372
-2,631
-800
-1,600
-2,400
-3,200
-3,200
-49,245
-49,101
-556
-259
-1,187
-4,872
-436
-4,351
267
83
-375
539
458
374
288
200
105
0
936
867
796
724
649
6497247968679360105200288374458539-37583267-4,351-436-4,872-1,187-259-556-49,101-49,245-3,200-3,200-2,400-1,600-800-2,6311,372-2,400-2,333-1,733-1,13300-1,7330
       Long-term Liabilities Other 
0
0
0
0
0
0
0
79
251
0
0
0
0
0
0
0
0
0
1,130
1,035
961
897
832
762
689
616
539
458
374
288
0
105
31,935
34,913
37,011
38,088
40,710
42,468
42,46840,71038,08837,01134,91331,93510502883744585396166897628328979611,0351,130000000000251790000000
       Deferred Long Term Liability 
0
1,750
0
0
0
410
0
170
165
160
718
757
782
750
581
550
524
605
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000060552455058175078275771816016517004100001,7500
> Total Stockholder Equity
1,133
-19,213
0
0
-31,560
-36,659
5,466
45,896
-55,599
71,659
67,163
54,326
36,895
21,415
85,931
66,672
44,081
23,620
16,091
12,901
9,759
11,157
10,440
7,287
8,124
8,763
16,985
19,338
17,848
37,975
31,703
25,248
18,546
10,607
2,700
-4,973
-12,849
-15,912
-15,912-12,849-4,9732,70010,60718,54625,24831,70337,97517,84819,33816,9858,7638,1247,28710,44011,1579,75912,90116,09123,62044,08166,67285,93121,41536,89554,32667,16371,659-55,59945,8965,466-36,659-31,56000-19,2131,133
   Common Stock
3
4
0
0
5
3
12
20
21
25
25
25
25
25
32
32
32
32
37
38
41
44
45
46
48
52
58
59
60
60
60
60
60
61
61
62
62
63
6362626161606060606059585248464544413837323232322525252525212012350043
   Retained Earnings Total Equity000-297,718-288,438-278,775-270,948-263,135-255,491-274,200-269,313-263,218-255,867-248,755-246,322-240,568-237,657-234,561-228,025-222,291-206,887-185,240-161,368-140,667-124,220-107,727-89,391-75,618-65,245-55,559-49,9140000000
   Accumulated Other Comprehensive Income 
0
-55
0
0
-88
-103
-120
-135
-5
-13
-21
-23
-8
-8
-1
1
-4
-409
-462
-516
-569
-597
-642
-687
-733
0
-822
0
0
0
0
0
0
0
0
0
0
0
00000000000-8220-733-687-642-597-569-516-462-409-41-1-8-8-23-21-13-5-135-120-103-8800-550
   Capital Surplus 
0
0
0
0
0
0
0
95,790
102,481
136,892
142,777
143,715
144,605
145,618
226,567
228,007
229,293
230,475
238,345
240,888
244,279
248,770
250,963
253,563
256,831
264,578
280,145
288,592
291,988
293,406
294,778
296,136
297,261
298,984
300,357
0
0
0
000300,357298,984297,261296,136294,778293,406291,988288,592280,145264,578256,831253,563250,963248,770244,279240,888238,345230,475229,293228,007226,567145,618144,605143,715142,777136,892102,48195,7900000000
   Treasury Stock00000000000000000000000000000000000000
   Other Stockholders Equity 
0
2,562
0
0
2,716
2,804
50,386
39,761
-57,787
136,892
142,777
143,715
144,605
145,618
226,567
228,007
229,293
230,475
238,807
241,404
244,848
249,367
251,605
254,250
257,564
264,578
280,967
288,592
291,988
293,406
294,778
296,136
297,261
298,984
300,357
301,789
303,180
304,948
304,948303,180301,789300,357298,984297,261296,136294,778293,406291,988288,592280,967264,578257,564254,250251,605249,367244,848241,404238,807230,475229,293228,007226,567145,618144,605143,715142,777136,892-57,78739,76150,3862,8042,716002,5620



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue8,226
Cost of Revenue-422
Gross Profit7,8047,804
 
Operating Income (+$)
Gross Profit7,804
Operating Expense-32,648
Operating Income-24,844-24,844
 
Operating Expense (+$)
Research Development20,779
Selling General Administrative11,869
Selling And Marketing Expenses0
Operating Expense32,64832,648
 
Net Interest Income (+$)
Interest Income0
Interest Expense-9,360
Other Finance Cost-0
Net Interest Income-9,360
 
Pretax Income (+$)
Operating Income-24,844
Net Interest Income-9,360
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-32,485-17,203
EBIT - interestExpense = -34,204
-32,485
-23,125
Interest Expense9,360
Earnings Before Interest and Taxes (EBIT)-24,844-23,125
Earnings Before Interest and Taxes (EBITDA)-24,777
 
After tax Income (+$)
Income Before Tax-32,485
Tax Provision-0
Net Income From Continuing Ops-32,485-32,485
Net Income-32,485
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses33,070
Total Other Income/Expenses Net-7,6419,360
 

Technical Analysis of Clearside Biomedical Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Clearside Biomedical Inc. The general trend of Clearside Biomedical Inc is BULLISH with 14.3% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Clearside Biomedical Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (14.3%) Bearish trend (-14.3%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Clearside Biomedical Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 1.4901 < 2.12.

The bearish price targets are: 1.19 > 1.1 > 0.9243.

Tweet this
Clearside Biomedical Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Clearside Biomedical Inc. The current mas is .

The long score for the Moving Averages is 8/14.
The longshort score for the Moving Averages is 2/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Clearside Biomedical Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Clearside Biomedical Inc. The current macd is -0.07771532.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Clearside Biomedical Inc price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Clearside Biomedical Inc. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Clearside Biomedical Inc price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Clearside Biomedical Inc Daily Moving Average Convergence/Divergence (MACD) ChartClearside Biomedical Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Clearside Biomedical Inc. The current adx is 32.55.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -3/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Clearside Biomedical Inc shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bearish trend. The ADX is declining, the bearish trend is weakening. Could be a potential reversal to the upside. -2
Clearside Biomedical Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Clearside Biomedical Inc. The current sar is 1.52183482.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Clearside Biomedical Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Clearside Biomedical Inc. The current rsi is 45.76. The current phase is Correction in bull market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Correction in bull market: Moderate price decline, potential pause in the uptrend. Reassess the market, wait for signs of stabilization.
  • Trending up: The RSI is trending up. +1
Clearside Biomedical Inc Daily Relative Strength Index (RSI) ChartClearside Biomedical Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Clearside Biomedical Inc. The current phase is Correction in bull market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 2/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Clearside Biomedical Inc price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Clearside Biomedical Inc Daily Stochastic Oscillator ChartClearside Biomedical Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Clearside Biomedical Inc. The current cci is -44.44435718.

Clearside Biomedical Inc Daily Commodity Channel Index (CCI) ChartClearside Biomedical Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Clearside Biomedical Inc. The current cmo is -6.05319659.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Clearside Biomedical Inc Daily Chande Momentum Oscillator (CMO) ChartClearside Biomedical Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Clearside Biomedical Inc. The current willr is -58.39636914.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Clearside Biomedical Inc is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Clearside Biomedical Inc Daily Williams %R ChartClearside Biomedical Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Clearside Biomedical Inc.

Clearside Biomedical Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Clearside Biomedical Inc. The current atr is 0.15325789.

Clearside Biomedical Inc Daily Average True Range (ATR) ChartClearside Biomedical Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Clearside Biomedical Inc. The current obv is 555,315.

Clearside Biomedical Inc Daily On-Balance Volume (OBV) ChartClearside Biomedical Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Clearside Biomedical Inc. The current mfi is 18.62.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -2/(-2 +2).

  • MFI < 50: -1
  • MFI < 20: -1
Clearside Biomedical Inc Daily Money Flow Index (MFI) ChartClearside Biomedical Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Clearside Biomedical Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-29WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-11-30STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-01STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-04CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-05STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-06BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-12-07STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-08STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-11SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-13STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-14DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2023-12-15STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-26WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-27MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-28STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-29MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-02STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-03ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-05RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-08STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-10WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-12RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-16MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-17SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-18MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-19DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-01-22WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-24STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-25DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-29CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-31SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-05WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-06MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-07STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-13MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-15WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-21DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-02-22CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-27MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-28WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-06CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-07STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-12RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-13MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-14STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-18SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-19CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-20MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-21MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-03-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-26MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-03-28CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-02DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-04STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-10STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-16STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-17STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Clearside Biomedical Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Clearside Biomedical Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5045.762
Ma 20Greater thanMa 501.428
Ma 50Greater thanMa 1001.450
Ma 100Greater thanMa 2001.327
OpenGreater thanClose1.280
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Clearside Biomedical Inc with someone you think should read this too:
  • Are you bullish or bearish on Clearside Biomedical Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Clearside Biomedical Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Clearside Biomedical Inc

I send you an email if I find something interesting about Clearside Biomedical Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Clearside Biomedical Inc.

Receive notifications about Clearside Biomedical Inc in your mailbox!